tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $2.44. This is a potential upside of $2.38 (3966.67%) from yesterday's end of day stock price of $0.06.
Rubius Therapeutics's activity chart (see below) currently has 29 price targets and 28 ratings on display.
Analysts average stock forecasts to be materialized ratio is 49.44% with an average time for these price targets to be met of 127.5 days.
Most recent stock forecast was given by MICHAEL SCHMIDT from GUGGENHEIM on 13-Sep-2022. First documented stock forecast 13-Aug-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5
2 years 4 months 6 days ago
(13-Sep-2022)
2/4 (50%)
$2.59 (107.47%)
488
Hold
$1.5
$1.44 (2400.00%)
$2
2 years 4 months 10 days ago
(09-Sep-2022)
0/4 (0%)
$0.38 (33.93%)
Hold
$1
$0.94 (1566.67%)
2 years 5 months 10 days ago
(09-Aug-2022)
4/5 (80%)
$0.2 (25.00%)
245
Hold
2 years 8 months 8 days ago
(11-May-2022)
2/3 (66.67%)
$0.49 (5.15%)
5
Buy
2 years 8 months 8 days ago
(11-May-2022)
0/3 (0%)
$9.71 (32.06%)
What is RUBY (Rubius Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RUBY (Rubius Therapeutics) with a proven track record?
Which analyst has the current lower performing score on RUBY (Rubius Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RUBY (Rubius Therapeutics)?
Which analyst is the currently most bullish on RUBY (Rubius Therapeutics)?
Which analyst is the currently most reserved on RUBY (Rubius Therapeutics)?
